Literature DB >> 31287590

On the relationship between VDR, RORα and RORγ receptors expression and HIF1-α levels in human melanomas.

Anna A Brożyna1,2, Wojciech Jóźwicki2,3, Anton M Jetten4, Andrzej T Slominski5,6.   

Abstract

We analysed the correlation between the expression of HIF-1α (hypoxia-inducible factor 1 alpha), the nuclear receptors: VDR (vitamin D receptor), RORα (retinoic acid receptor-related orphan receptor alpha), and RORγ and CYP24A1 (cytochrome P450 family 24 subfamily A member 1) and CYP27B1 (cytochrome P450 family 27 subfamily B member 1), enzymes involved in vitamin D metabolism. In primary and metastatic melanomas, VDR negatively correlated with nuclear HIF-1α expression (r = -.2273, P = .0302; r = -.5081, P = .0011). Furthermore, the highest HIF-1α expression was observed in pT3-pT4 VDR-negative melanomas. A comparative analysis of immunostained HIF-1α and CYP27B1 and CYP24A1 showed lack of correlation between these parameters both in primary tumors and melanoma metastases. In contrast, RORα expression correlated positively with nuclear HIF-1α expression in primary and metastatic lesions (r = .2438, P = .0175; r = .3662, P = .0166). Comparable levels of HIF-1α expression pattern was observed in localized and advanced melanomas. RORγ in primary melanomas correlated also positively with nuclear HIF-1α expression (r = .2743, P = .0129). HIF-1α expression was the lowest in localized RORγ-negative melanomas. In addition, HIF-1α expression correlated with RORγ-positive lymphocytes in melanoma metastases. We further found that in metastatic lymph nodes FoxP3 immunostaining correlated positively with HIF-1α and RORγ expression in melanoma cells (r = .3667; P = .0327; r = .4208, P = .0129). In summary, our study indicates that the expression of VDR, RORα and RORγ in melanomas is related to hypoxia and/or HIF1-α activity, which also affects FoxP3 expression in metastatic melanoma. Therefore, the hypoxia can affect tumor biology by changing nuclear receptors expression and molecular pathways regulated by nuclear receptors and immune responses.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hypoxia-inducible factor; melanoma; retinoic acid receptor-related orphan receptor; vitamin D; vitamin D receptor

Year:  2019        PMID: 31287590      PMCID: PMC6715521          DOI: 10.1111/exd.14002

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  68 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.

Authors:  Barbara Bedogni; Scott M Welford; David S Cassarino; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  Cancer Cell       Date:  2005-12       Impact factor: 31.743

3.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; C Plank; G Breitenecker; G Oberhuber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

4.  1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells.

Authors:  Moshe Ben-Shoshan; Sharon Amir; Duyen T Dang; Long H Dang; Yosef Weisman; Nicola J Mabjeesh
Journal:  Mol Cancer Ther       Date:  2007-04       Impact factor: 6.261

5.  Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the predominant isoform of the nuclear receptor RORalpha in the liver and is up-regulated by hypoxia in HepG2 human hepatoma cells.

Authors:  Caroline Chauvet; Brigitte Bois-Joyeux; Jean-Louis Danan
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Kouskoukis; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Journal:  Melanoma Res       Date:  2003-10       Impact factor: 3.599

Review 7.  Melanin pigmentation in mammalian skin and its hormonal regulation.

Authors:  Andrzej Slominski; Desmond J Tobin; Shigeki Shibahara; Jacobo Wortsman
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

8.  The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1.

Authors:  Caroline Chauvet; Brigitte Bois-Joyeux; Edurne Berra; Jacques Pouyssegur; Jean-Louis Danan
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

9.  Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor alpha4 gene by an interaction between hypoxia-inducible factor-1 and Sp1.

Authors:  Naoki Miki; Megumi Ikuta; Takashi Matsui
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

Review 10.  The role of hypoxia-inducible factors in tumorigenesis.

Authors:  E B Rankin; A J Giaccia
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828

View more
  11 in total

1.  CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.

Authors:  Andrzej T Slominski; Anna A Brożyna; Tae-Kang Kim; Mahmoud M Elsayed; Zorica Janjetovic; Shariq Qayyum; Radomir M Slominski; Allen S W Oak; Changzhao Li; Ewa Podgorska; Wei Li; Anton M Jetten; Robert C Tuckey; Edith K Y Tang; Craig Elmets; Mohammad Athar
Journal:  Int J Oncol       Date:  2022-07-01       Impact factor: 5.884

2.  Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer.

Authors:  Lizhe Zhu; Shibo Yu; Siyuan Jiang; Guanqun Ge; Yu Yan; Yuhui Zhou; Ligang Niu; Jianjun He; Yu Ren; Bin Wang
Journal:  PeerJ       Date:  2020-11-20       Impact factor: 2.984

3.  Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis.

Authors:  Jörg Reichrath; Florian Biersack; Stefan Wagenpfeil; Jakob Schöpe; Claudia Pföhler; Roman Saternus; Thomas Vogt
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

Review 4.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Relevance of Vitamin D in Melanoma Development, Progression and Therapy.

Authors:  Anna A Brożyna; Robert M Hoffman; Andrzej T Slominski
Journal:  Anticancer Res       Date:  2020-01       Impact factor: 2.480

6.  Maternal Vit D supplementation in AMA mice and the role of Vit D/VDR signaling in the offspring's cognition.

Authors:  Dao Li; Yawen Xu; Kai Wang; Zhuanhong Yang; Hui Li; Sijia Lei; Suqing Wang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

7.  Association among Vitamin D, Retinoic Acid-Related Orphan Receptors, and Vitamin D Hydroxyderivatives in Ovarian Cancer.

Authors:  Anna A Brożyna; Tae-Kang Kim; Marzena Zabłocka; Wojciech Jóźwicki; Junming Yue; Robert C Tuckey; Anton M Jetten; Andrzej T Slominski
Journal:  Nutrients       Date:  2020-11-19       Impact factor: 5.717

8.  Deciphering the Functional Role of RIPK4 in Melanoma.

Authors:  Ewelina Madej; Damian Ryszawy; Anna A Brożyna; Malgorzata Czyz; Jaroslaw Czyz; Agnieszka Wolnicka-Glubisz
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

9.  Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells.

Authors:  Ewa Podgorska; Tae-Kang Kim; Zorica Janjetovic; Krystyna Urbanska; Robert C Tuckey; Sejong Bae; Andrzej T Slominski
Journal:  Cancers (Basel)       Date:  2021-06-22       Impact factor: 6.639

Review 10.  The Role of the Vitamin D Receptor in the Pathogenesis, Prognosis, and Treatment of Cutaneous Melanoma.

Authors:  Alyssa L Becker; Evan L Carpenter; Andrzej T Slominski; Arup K Indra
Journal:  Front Oncol       Date:  2021-10-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.